Ray Dalio Abb Vie Inc. Transaction History

Bridgewater Associates, LP

$17.3 Billion
Q3 2024

A detailed history of Ray Dalio (Bridgewater Associates, LP) transactions in Abb Vie Inc. stock. As of the latest transaction made, Bridgewater Associates, LP holds 204,572 shares of ABBV stock, worth $36 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares

204,572

Previous 288,525 29.1%

Holding current value

$36 Million

Previous $49.5 Million 18.37%

% of portfolio

0.23%

Previous 0.26%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$163.84 - $199.33 $13.8 Million - $16.7 Million	-83,953 Reduced 29.1%	204,572 $40.4 Million
Q2 2024 Aug 14, 2024	SELL	$154.79 - $180.76 $25 Million - $29.1 Million	-161,254 Reduced 35.85%	288,525 $49.5 Million
Q1 2024 May 14, 2024	SELL	$159.82 - $182.1 $25.1 Million - $28.6 Million	-157,114 Reduced 25.89%	449,779 $81.9 Million
Q4 2023 Feb 14, 2024	BUY	$137.6 - $154.97 $4.26 Million - $4.79 Million	30,933 Added 5.37%	606,893 $94.1 Million
Q3 2023 Nov 13, 2023	SELL	$133.59 - $154.65 $7.79 Million - $9.02 Million	-58,345 Reduced 9.2%	575,960 $85.9 Million
Q2 2023 Aug 11, 2023	BUY	$132.51 - $164.9 $29.5 Million - $36.8 Million	222,875 Added 54.17%	634,305 $85.5 Million
Q1 2023 May 12, 2023	BUY	$144.61 - $166.54 $55.1 Million - $63.5 Million	381,328 Added 1266.79%	411,430 $65.6 Million
Q4 2022 Feb 13, 2023	SELL	$138.31 - $165.87 $25.3 Million - $30.3 Million	-182,648 Reduced 85.85%	30,102 $4.87 Million
Q3 2022 Nov 10, 2022	BUY	$134.21 - $153.93 $17.6 Million - $20.1 Million	130,900 Added 159.93%	212,750 $28.6 Million
Q2 2022 Aug 11, 2022	BUY	$137.62 - $174.96 $871,685 - $1.11 Million	6,334 Added 8.39%	81,850 $12.5 Million
Q1 2022 May 13, 2022	BUY	$131.98 - $163.75 $4.44 Million - $5.51 Million	33,661 Added 80.42%	75,516 $12.2 Million
Q4 2021 Feb 14, 2022	SELL	$107.43 - $135.93 $3.57 Million - $4.52 Million	-33,241 Reduced 44.26%	41,855 $5.67 Million
Q3 2021 Nov 12, 2021	BUY	$106.4 - $120.78 $2.39 Million - $2.72 Million	22,491 Added 42.75%	75,096 $8.1 Million
Q2 2021 Aug 13, 2021	BUY	$105.21 - $117.21 $5.53 Million - $6.17 Million	52,605 New	52,605 $5.93 Million
Q1 2021 May 14, 2021	SELL	$102.3 - $112.62 $2.59 Million - $2.85 Million	-25,294 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$80.49 - $108.67 $2.04 Million - $2.75 Million	25,294 New	25,294 $2.71 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $312B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track Ray Dalio's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgewater Associates, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bridgewater Associates, LP and Ray Dalio with notifications on news.

Account